Hims & Hers Shares Rise on FDA Plan to Loosen Restrictions on Peptides

By Nicholas G. Miller

Shares of Hims & Hers jumped after Secretary of Health and Human Services Robert F. Kennedy Jr. said the Food and Drug Administration would loosen restrictions on peptides.

The stock rose 8.6% to $26.39 in premarket trading after closing up 14% Wednesday.

Kennedy said on Wednesday that the FDA would remove several peptides from a category of drugs with significant safety risk. The FDA also said it would hold a meeting in July to discuss whether seven peptides should be allowed to be produced by compounding pharmacies.

Despite safety concerns and limited research evidence, peptides have grown in popularity as a strategy to build muscle or heal injuries.

Hims & Hers, which praised the FDA's move, acquired a peptide facility in California last year.

Write to Nicholas G. Miller at [e-mail].

(END) Dow Jones Newswires

04-16-26 0900ET